Trump pricing

President Donald Trump’s latest agreement with pharmaceutical giants Eli Lilly and Novo Nordisk could dramatically reshape the cost landscape for obesity treatments in the United States. The deal, announced from the Oval Office, sets a sliding scale of prices that varies by dosage, specific product, and the way a patient pays—whether through...